(Q54198270)

26 May 2018

meta-analysis

0 references

title

Salvage therapy for multiple myeloma: the University of Arkansas experience. (English)

1 reference

26 May 2018

author name string

B Barlogie

series ordinal

1

1 reference

26 May 2018

D H Vesole

series ordinal

2

1 reference

26 May 2018

S Jagannath

series ordinal

3

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 August 1994

1 reference

26 May 2018

published in

Mayo Clin Proc

1 reference

26 May 2018

volume

69

1 reference

26 May 2018

issue

8

1 reference

26 May 2018

page(s)

787-795

1 reference

26 May 2018

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

Management of refractory myeloma: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

High-dose glucocorticoid treatment of resistant myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

Alpha-interferon combination therapy of resistant myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

Management of multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961101-X

10.1016/S0025-6196(12)61101-X

7 January 2021

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018